Cancer markers of the 1900s: an introduction / Stewart Sell --;Clinical cancer markers: diagnosis, prognosis, and monitoring / Manfred L. Lüthgens and Peter Oehr --;Alpha-fetoprotein in the 1990s / Kazuhisa Taketa --;Carcinoembryonic antigen / Hanna M. Sikorska, Abraham Fuks, and Phil Gold --;Prostate-specific antigen / T. Ming Chu --;Enzyme markers / Doris Balinsky --;Alkaline phosphatases as tumor markers / Torgny Stigbrand and Britta Wahren --;Sex-associated hormones / Shahla Masood --;Tissue polypeptide antigen and specific TPA / Peter Oehr, Manfred L. Lüthgens, and Qian Liu --;Tumor-associated carbohydrate markers: chemical and physical basis and cell biological implications / Sen-itiroh Hakomori --;Glycoamines: structural-functional characterization of a new class of human tumor markers / Gennadi V. Glinsky --;CA 15-3 assay for the detection of episialin: a serum marker for breast cancer / John Hilkens --;Clinical applications of CA 15-3 / Daniel F. Hayes, Carlo Tondini, and Donald W. Kufe --;CA 19-9, GICA (gastrointestinal cancer antigen) / Rolf Lamerz. (cont.) Mucin-like cancer-associated antigen (MCA) as available circulating tumor marker for breast cancer / Emilio Bombardieri and Massino Gion --;DU-PAN-2: a clinically useful mucin marker of differentiation of pancreatic and other ductal cells and their tumors / Richard S. Metzgar, Norio Sawabu, and Michael A. Hollingsworth --;CA 50 / Caj Haglund [and others] --;TAG-72 as a tumor marker / Jeffrey Schlom [and others] --;CA 125 / Fredrick J. Montz --;CA 242 / Pentti Kuusela [and others] --;Squamous cell carcinoma antigen / Hiroshi Kato --;Tumor-marker detection by isotachophoresis in porous membranes: Bence-Jones protein in chronic lymphocytic leukemia and non-Hodgkin's lymphoma / Garri I. Abelev and Eleonora R. Karamova --;Multiple testing with cancer markers / Adolf L. Pohl --;New cancer products: predicting market success / N. Coleman Owen --;Comments / J.V. Klavins.
The purpose of this book-the fourth volume of a series on Can- cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can- cer, with an emphasis on cancer markers detected in the serum.